Two Sigma Advisers
TCRT icon

Two Sigma Advisers’s Alaunos Therapeutics TCRT Stock Holding History

Two Sigma Advisers’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-247
Closed -$2.62K – 2636
2023
Q4 		$2.62K Sell
247
-2,628
-91% -$31.7K ﹤0.01% 2477
2023
Q3 		$56.8K Sell
2,875
-1,380
-32% -$59.5K ﹤0.01% 2268
2023
Q2 		$326K Sell
4,255
-5,888
-58% -$476K ﹤0.01% 1963
2023
Q1 		$958K Sell
10,143
-2,776
-21% -$264K ﹤0.01% 1654
2022
Q4 		$1.26M Buy
12,919
+4,189
+48% +$607K ﹤0.01% 1464
2022
Q3 		$2.25M Sell
8,730
-4,276
-33% -$1.24M 0.01% 1114
2022
Q2 		$2.42M Sell
13,006
-5,239
-29% -$501K 0.01% 1115
2022
Q1 		$1.78M Sell
18,245
-3,642
-17% -$467K ﹤0.01% 1326
2021
Q4 		$3.58M Buy
21,887
+14,811
+209% +$3.25M 0.01% 922
2021
Q3 		$1.93M Buy
7,076
+611
+9% +$187K 0.01% 1279
2021
Q2 		$2.56M Buy
6,465
+44
+0.7% +$20.5K 0.01% 1176
2021
Q1 		$3.47M Buy
6,421
+495
+8% +$308K 0.01% 1015
2020
Q4 		$2.24M Buy
5,926
+2,609
+79% +$1.04M 0.01% 1199
2020
Q3 		$1.25M Buy
3,317
+2,576
+348% +$1.14M ﹤0.01% 1399
2020
Q2 		$365K Buy
741
+182
+33% +$81.2K ﹤0.01% 2034
2020
Q1 		$205K Buy
+559
New +$289K ﹤0.01% 2163
2019
Q1 		– Sell
-67
Closed -$19K – 2451
2018
Q4 		$19K Buy
+67
New +$26.5K ﹤0.01% 2313
2015
Q1 		– Sell
-128
Closed -$97K – 2365
2014
Q4 		$97K Buy
128
+42
+49% +$22.3K ﹤0.01% 2334
2014
Q3 		$34K Sell
86
-69
-45% -$33.3K ﹤0.01% 2262
2014
Q2 		$94K Buy
155
+70
+82% +$39K ﹤0.01% 2369
2014
Q1 		$59K Buy
+85
New +$56.9K ﹤0.01% 2199

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Two Sigma Advisers's TCRT Position: Q1 2024 in Review

Two Sigma Advisers sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 247 shares — an estimated $2.62K sold.

Two Sigma Advisers first reported a position in TCRT in Q1 2014 and held it in 21 quarters. The position peaked at $3.58M in Q4 2021. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Two Sigma Advisers reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 247 Alaunos Therapeutics shares in Q1 2024, an estimated $2.62K.
  • Two Sigma Advisers first reported a position in Alaunos Therapeutics in Q1 2014 and held it in 21 quarters.
  • Two Sigma Advisers's Alaunos Therapeutics position peaked at $3.58M in Q4 2021.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Two Sigma Advisers's 13F filing for Q1 2024, filed 15 May 2024.